SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Sepracor-Looks very promising
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
10280 115 0 SEPR
Emcee:  rkrw Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
8255Repeat with corrections: Put another collar on today, since the old one expiredRocky9-4/18/2005
8254Put another collar on today, since the old one expired on Friday. At loser priceRocky9-4/18/2005
8253Peter, Not far enough in yet to tell. They are I think judging every script toRobohogs-4/18/2005
8252Jon, There's no doubt the drug works. It may not work in a small hard-core Biomaven-4/18/2005
8251Yes the two factors in my mind that will build scripts are DTC campaign with speRobohogs-4/18/2005
8250<i>if the drug does not work</i> If someone has been on an benzo, oBiomaven-4/18/2005
8249Well, if the drug does not work (like many on Cafepharma and YMB are saying), thRobohogs-4/18/2005
8248My best guess would be for approvable and a late 2006 launch. The whole thing rkrw-4/15/2005
8247I'm with Peter, here. Have watched NBIX for a long time, but still not a butuck-4/15/2005
8246I don't think they will get one-cycle approval - the multiple dosing levels Biomaven-4/15/2005
8245Yes, that is what I believe. Unless one counts the step already taken. ErikIcebrg-4/15/2005
8244[EDIT] I just saw Jon's breakdown. confusion does seem to be the order of thquidditch-4/15/2005
8243So one stage approval, Eric? JonRobohogs-4/15/2005
8242Capsules=IR and tablets=MR. MS thinks the whole mess stinks to high heaven giveRobohogs-4/15/2005
8241I think it will be approved, but I think you're right, final approval on therkrw-4/15/2005
8240Approved, as the agency is getting more comfortable with this class of drugs. Icebrg-4/15/2005
8239I just perused the NBIX commentary from analysts post MR (excuse me, capsule) fiRobohogs-4/15/2005
8238The 27 and 31 are monthly projections - sorry for the confusion. JonRobohogs-4/12/2005
8237<i>>>…definitely hard to see sepr out selling them given pfe weight DewDiligence_on_SI-4/12/2005
8236Blurb from today’s NY Times apropos to Lunesta: investorshub.comDewDiligence_on_SI-4/12/2005
8235<<Cowen sees PFE/NBIX drug at 1.5x Lunesta by 2009 and ahead already by 20rkrw-4/12/2005
8234Jonathan, It's just a risk thang. Fade to 30,000 feet and the potential of Sam Citron-4/12/2005
8233Just continuing the info flow - no editorializing (to extent I can help it). SGRobohogs-4/12/2005
8232My bad - using the free version of the software and it had auto input of 5.5% foRobohogs-4/12/2005
8231<i>put vols are not in line with call vols</i> Might be you need toBiomaven-4/12/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News